Medical Device News

Gaining Informational Advantage with Proprietary Alt Data – By Julia Valentine, MBA

AI-Amp’d Industry Intel: How medical companies are actively expanding their informational advantage by incorporating alt data into their risk, R&D, investment and other key processes

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

By Julia Valentine, MBA

Imagine a world where perfect market research information is available to everyone at the same time. In this scenario, the concepts of investment and business competition would be radically changed—not just within the medical and healthcare sectors but far beyond. If perfect information were available to everyone, it would be difficult if not impossible for any one entity to identify an underserved market or underpriced asset. When companies and investors develop the expertise to spot mispricing and other indicators and anomalies, they often start with identifying a way to collect vital data that provides an informational advantage over their competition.

The most obvious way in which main street companies and investment funds gain an informational advantage is through developing a proprietary way to collect data. Alternative data, or data that supplements traditional financial data available through annual financial reports or exchanges, provides a valuable window into market or consumer behavior. Satellite data can track shipments and parking lots. Credit card data can illuminate who’s spending what and where.

Most companies buy data feeds from over 400 alternative data providers. So prolific is this emerging sector, a recent report reveals the global alternative data market size is anticipated to reach $143.31 billion by 2030 driven, in large party, by the escalating number of data providers coupled with ever-evolving procurement and extraction methods. While North America currently dominates the space (67%) and is forecasted to do so through 2030, alt data-driven market research is also burgeoning globally.

However procured and analyzed, one thing is certain: companies slow to use alt data expose themselves to extreme opportunity loss at best and operational peril at worst–as addressed in the topics list bulleted below.

Proprietary ways to acquire and combine alternative data for added insight are essential. While using available sources of alternative data certainly add insight, truly proprietary data can be collected through the use of multi-modal AI. Multimodal AI is a new AI paradigm in which various data types (image, text, speech, numerical data) are combined with multiple intelligence processing algorithms to achieve higher performances.

Companies using multi-modal AI amplify their competitive advantage due to faster data collection and improved ability to programmatically turn long form content (visual, audio, text) into relevant pieces of information resulting in significant time efficiencies and faster decision making. Multimodal AI often outperforms single modal AI in many real-world problems. Proprietary data can be collected from social media, web and other sources that are not available to the competition.

When proprietary data is collected, timely analysis makes a difference. In a rapidly changing world, it’s essential to operate with timely and accurate data. Research & Development departments need to react to the current customer needs. Investment firms react to rapidly changing market conditions. Every market player needs to consider how to utilize alternative data in the best possible way.

Agile companies pivot quickly when they are able to obtain proprietary data and analyze it quickly. Wholesalers and retailers can change their inventory every few weeks because they can analyze their sales data, trends and other data points in a timely way and create the merchandise that answers identified up-to-the-minute consumer behaviors. Gaining insights from alternative data is only valuable when they can be parlayed into market action in a way that is cleverly conceived and masterfully executed.

Editor’s Note: Julia Valentine, MBA,  a solution-focused FinTech Advisor to boards and management teams,  is Managing Partner at AlphaMille—a full-service company providing technology advisory and consulting services worldwide relating to software development and implementation, data analytics and data management, model valuation, and more.   

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.